VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV was delisted on the 7th of August, 2024.
114 hedge funds and large institutions have $361M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2020 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 38 increasing their positions, 40 reducing their positions, and 15 closing their positions.
80% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 15
18% more capital invested
Capital invested by funds: $306M → $361M (+$55.4M)
12% more funds holding
Funds holding: 102 → 114 (+12)
5% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 40
36% less call options, than puts
Call options by funds: $2.98M | Put options by funds: $4.65M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$60.6M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
+$34.2M |
| 3 |
Millennium Management
New York
|
+$5.4M |
| 4 |
Charles Schwab
San Francisco,
California
|
+$3.44M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$2.69M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.84M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$3.61M |
| 3 |
BlackRock
New York
|
-$3.3M |
| 4 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$1.86M |
| 5 |
DCM
Dupont Capital Management
Wilmington,
Delaware
|
-$939K |
VBIV Hedge Fund Activity: Q3 2020 in Review
114 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) for Q3 2020, worth a combined $361M — up 18% from $306M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new VBIV positions and 15 closed out — a net gain of 12 holders — while 38 added to existing stakes and 40 trimmed.
The largest buyer was State Street, adding an estimated $60.6M. The largest seller was Vanguard Group, cutting an estimated $3.84M.
- 114 institutional investors held VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) as of Q3 2020, up from 102 in Q2 2020.
- Funds reported $361M of VBI Vaccines, Inc. New Common Stock (Canada) stock for Q3 2020, up 18% quarter-over-quarter.
- 27 funds opened new VBI Vaccines, Inc. New Common Stock (Canada) positions in Q3 2020 and 15 closed out, a net change of +12 holders.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) buyer in Q3 2020 was State Street, an estimated $60.6M added.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) seller in Q3 2020 was Vanguard Group, an estimated $3.84M sold.
Based on aggregated 13F filings for Q3 2020.